Lundbeck Neurogenic Orthostatic Hypotension protocol #16306A <- click for more information
Basic Eligibility Criteria:
- 18 Years and older and able to stand
- Clinical diagnosis of symptomatic orthostatic hypotension associated with Primary Autonomic Failure
- Patients who are taking prescribed droxidopa therapy are eligible to participate in the study if they meet the other inclusion criteria and also have been on a stable dose of prescribed droxidopa for at least 2 weeks prior to the Screening Visit
-------------------
If you would like further information about any of our Clinical Trials at Associated Neurologists of Southern Connecticut, please feel free to contact any of our Research staff:
Irina Gamerman, M.D., Clinical Research Manager, at [email protected]
Clinical Research Coordinator:
Micah Sy at [email protected]
You may also call 203.333.1151 and we will be happy to answer any of your questions.